Dr. Blalock is an associate professor in the Division of Pharmaceutical Outcomes and Policy. She is a behavioral scientist with expertise in the area of patient and public health education and is particularly interested in risk communication and the impact of pharmaceutical care, including patient education and counseling, on patient health outcomes. Her research focuses primarily on the prevention and treatment of rheumatoid arthritis, osteoarthritis, and osteoporosis. Her current work includes studies evaluating the impact of community-pharmacy based illness prevention and disease management programs.

Research Interests

Health outcomes assessment, risk communication, psychosocial aspects of chronic illness, patient decision-making and adherence to therapeutic regimens